{"nct_id":"NCT00372944","title":"AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy","status":"COMPLETED","status_verified_date":"2014-08","start_date":"2006-08","start_date_type":null,"primary_completion_date":"2008-04","primary_completion_date_type":"ACTUAL","completion_date":"2008-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}